Yield10 Bioscience, Inc. (YTEN)
OTCMKTS
· Delayed Price · Currency is USD
0.750
+0.090 (13.64%)
Oct 24, 2024, 10:04 AM EDT
Yield10 Bioscience Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.75 | 0.06 | 0.45 | 0.61 | 0.8 | 0.81 | Upgrade
|
| Revenue Growth (YoY) | 190.70% | -86.67% | -26.71% | -23.15% | -0.87% | 44.96% | Upgrade
|
| Cost of Revenue | 7.21 | 8.32 | 7.75 | 6.2 | 5.22 | 4.85 | Upgrade
|
| Gross Profit | -6.46 | -8.26 | -7.3 | -5.59 | -4.42 | -4.04 | Upgrade
|
| Selling, General & Admin | 6.16 | 6.15 | 6.15 | 6.11 | 5.05 | 4.55 | Upgrade
|
| Operating Expenses | 6.14 | 6.15 | 6.15 | 6.11 | 5.05 | 4.55 | Upgrade
|
| Operating Income | -12.59 | -14.42 | -13.45 | -11.69 | -9.47 | -8.6 | Upgrade
|
| Interest Expense | -0.04 | -0.04 | - | - | - | - | Upgrade
|
| Interest & Investment Income | - | - | 0.04 | - | - | 0.12 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.07 | - | - | -0 | -0.87 | 8.29 | Upgrade
|
| EBT Excluding Unusual Items | -12.7 | -14.46 | -13.41 | -11.7 | -10.34 | -0.19 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 0.7 | - | -13.02 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.14 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.33 | - | Upgrade
|
| Pretax Income | -12.7 | -14.46 | -13.41 | -11 | -10.15 | -13.21 | Upgrade
|
| Income Tax Expense | - | - | 0.16 | 0.04 | 0.06 | -0.25 | Upgrade
|
| Earnings From Continuing Operations | -12.7 | -14.46 | -13.57 | -11.03 | -10.21 | -12.96 | Upgrade
|
| Net Income | -12.7 | -14.46 | -13.57 | -11.03 | -10.21 | -12.96 | Upgrade
|
| Net Income to Common | -12.7 | -14.46 | -13.57 | -11.03 | -10.21 | -12.96 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 137.43% | 61.69% | 3.86% | 99.38% | 550.27% | 46.98% | Upgrade
|
| EPS (Basic) | -24.93 | -43.66 | -66.25 | -55.95 | -103.21 | -851.98 | Upgrade
|
| EPS (Diluted) | -24.93 | -43.66 | -66.25 | -55.95 | -103.21 | -851.98 | Upgrade
|
| Free Cash Flow | -5.82 | -10.11 | -11.56 | -9.44 | -8.74 | -8.72 | Upgrade
|
| Free Cash Flow Per Share | -11.42 | -30.55 | -56.44 | -47.89 | -88.33 | -573.09 | Upgrade
|
| Operating Margin | -1679.07% | -24028.33% | -2989.11% | -1904.23% | -1184.98% | -1066.50% | Upgrade
|
| Profit Margin | -1693.60% | -24091.67% | -3014.67% | -1796.58% | -1277.35% | -1607.44% | Upgrade
|
| Free Cash Flow Margin | -775.73% | -16856.67% | -2568.44% | -1537.79% | -1093.24% | -1081.27% | Upgrade
|
| EBITDA | -12.32 | -14.13 | -13.19 | -11.47 | -9.29 | -8.39 | Upgrade
|
| D&A For EBITDA | 0.27 | 0.29 | 0.26 | 0.22 | 0.18 | 0.2 | Upgrade
|
| EBIT | -12.59 | -14.42 | -13.45 | -11.69 | -9.47 | -8.6 | Upgrade
|
| Revenue as Reported | 0.75 | 0.06 | 0.45 | 0.61 | 0.8 | 0.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.